Literature DB >> 10457540

Effects of repeated high-dose methamphetamine on local cerebral glucose utilization in rats.

Y H Huang1, S J Tsai, T W Su, C B Sim.   

Abstract

Repeated administration of high doses of methamphetamine (MAP) to rats can induce long-lasting neurotoxicity which may be related to permanent psychotic symptoms and negative symptoms in some MAP psychotic patients. In this study, we used the 2-[14C]deoxyglucose (2DG) method to analyze the effects of repeated MAP administration (12.5 mg/kg, i.p., 4 times every 2 hr within a day) 14 days and 60 days after drug administration. The results showed a widespread (26 of the 43 regions examined) decreases in the regional cerebral glucose utilization. The regions with decrease metabolism included all the extrapyramidal systems, the hippocampus formation and dorsal raphe nucleus. Rats tested 60 days after drug administration has similar finding to those with a 14-day abstinent period. The results of the functional change in this study provide support for the neurotoxic effects of repeated high dose MAP administration in rats. Furthermore, the neurotoxic effects are selective and long-lasting. We suggested the MAP neurotoxic model can be used to study the permanent psychosis and negative symptoms of MAP-induced psychosis in humans.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10457540     DOI: 10.1016/S0893-133X(99)00029-9

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   7.853


  10 in total

1.  Cortical ionotropic glutamate receptor antagonism protects against methamphetamine-induced striatal neurotoxicity.

Authors:  N B Gross; P C Duncker; J F Marshall
Journal:  Neuroscience       Date:  2011-09-16       Impact factor: 3.590

2.  Effects of maternal separation and methamphetamine exposure on protein expression in the nucleus accumbens shell and core.

Authors:  J J Dimatelis; V A Russell; D J Stein; W M Daniels
Journal:  Metab Brain Dis       Date:  2012-03-28       Impact factor: 3.584

3.  Methamphetamine Induces Anhedonic-Like Behavior and Impairs Frontal Cortical Energetics in Mice.

Authors:  Raquel Fonseca; Rui A Carvalho; Cristina Lemos; Ana C Sequeira; Inês R Pita; Fábio Carvalho; Carlos D Silva; Rui D S Prediger; Ivana Jarak; Rodrigo A Cunha; Carlos A Fontes Ribeiro; Attila Köfalvi; Frederico C Pereira
Journal:  CNS Neurosci Ther       Date:  2016-10-19       Impact factor: 5.243

Review 4.  Neuroimmunometabolism: A New Pathological Nexus Underlying Neurodegenerative Disorders.

Authors:  Swarup Mitra; Avijit Banik; Sumit Saurabh; Malabika Maulik; Shailesh N Khatri
Journal:  J Neurosci       Date:  2022-01-13       Impact factor: 6.709

Review 5.  The role of oxidative stress, metabolic compromise, and inflammation in neuronal injury produced by amphetamine-related drugs of abuse.

Authors:  Bryan K Yamamoto; Jamie Raudensky
Journal:  J Neuroimmune Pharmacol       Date:  2008-08-15       Impact factor: 4.147

6.  Neuronal dysfunction of a long projecting multisynaptic pathway in response to methamphetamine using manganese-enhanced MRI.

Authors:  Yi-Hua Hsu; Chiao-Chi V Chen; Anil Zechariah; Cecil C Yen; Li-Chuan Yang; Chen Chang
Journal:  Psychopharmacology (Berl)       Date:  2007-11-14       Impact factor: 4.530

Review 7.  Neurotoxicity of methamphetamine and 3,4-methylenedioxymethamphetamine.

Authors:  Laura E Halpin; Stuart A Collins; Bryan K Yamamoto
Journal:  Life Sci       Date:  2013-07-24       Impact factor: 5.037

8.  Impairment of brain endothelial glucose transporter by methamphetamine causes blood-brain barrier dysfunction.

Authors:  P M Abdul Muneer; Saleena Alikunju; Adam M Szlachetka; L Charles Murrin; James Haorah
Journal:  Mol Neurodegener       Date:  2011-03-22       Impact factor: 14.195

9.  Chronic Methamphetamine Effects on Brain Structure and Function in Rats.

Authors:  Panayotis K Thanos; Ronald Kim; Foteini Delis; Mala Ananth; George Chachati; Mark J Rocco; Ihssan Masad; Jose A Muniz; Samuel C Grant; Mark S Gold; Jean Lud Cadet; Nora D Volkow
Journal:  PLoS One       Date:  2016-06-08       Impact factor: 3.240

10.  Methamphetamine regulation of activity and topology of ventral midbrain networks.

Authors:  Douglas R Miller; Joseph J Lebowitz; Dylan T Guenther; Alexander J Refowich; Carissa Hansen; Andrew P Maurer; Habibeh Khoshbouei
Journal:  PLoS One       Date:  2019-09-19       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.